Walgreens’ cough-cold offering to be featured on TaskRabbit app
CHICAGO — Walgreens’ latest omnichannel offering features a partnership with TaskRabbit, an online mobile marketplace that will deliver OTC cold medicines anywhere within the 19 cities in which the service exists, according to a report published by Mashable on Monday.
According to the report, the partnership runs this week through Feb. 18. The Walgreens OTC offering will be featured in TaskRabbit’s iOS app’s Task Wheel and on the TaskRabbit website.
CHPA: Industry efforts to promote safe OTC use through standardized dosing directions and devices is working
WASHINGTON — The Consumer Healthcare Products Association reported the makers of over-the-counter pediatric liquid medications have made significant progress in carrying out voluntary efforts to promote safe use through standardized dosing directions and dosing devices, as underscored by the results of a Centers for Disease Control and Prevention study released Monday in Pediatrics.
In 2009, CHPA members approved voluntary labeling guidelines for all pediatric liquid medications in an effort to reduce the potential for dosing errors. Following reports of unintentional overdoses in 2011, the Food and Drug Administration finalized similar recommendations for standardizing labeling and dosing devices included with OTC liquid medications.
The Pediatrics report found high levels of adherence to most recommendations provided in the final FDA guidance, as well as the CHPA guidelines.
“This report shows that our industry is making great progress, and it demonstrates our commitment to proactively working to empower consumers to safely use our products in order to reduce treatment errors in children,” said Barbara Kochanowski, CHPA’s VP regulatory and scientific affairs. “Hand in hand with our efforts to improve labeling is our commitment to educating parents about the importance of safe medicine storage. Accidental, unsupervised medicine ingestions are the leading cause of emergency department visits related to medication exposure, and reminding parents to store all medicines out of the reach and sight of young children is a top CHPA priority.”
Top-tier recommendations from the 2011 FDA voluntary guidance and 2009 CHPA voluntary guidance include the following:
- Dosing devices should be included with all products;
- Atypical units, such as drams or dropperfuls, should not be used;
- Teaspoon and tablespoon units should not be used together;
- Trailing zeros should not be used (to avoid 10-fold dosing errors);
- Leading zeros should be used before decimal doses (again, to avoid 10-fold dosing errors);
- Small font should be used with numerals in fractions (to avoid interpreting “1/2” as “1 or 2”);
- Dosing devices should not bear extraneous or unnecessary volumetric units;
- Dosing devices should not be significantly larger than the largest doses in the directions; and
- Dosing devices should provide markings that can readily measure doses in the directions.
Nutra Pharma ships initial product orders of Nyloxin to MyNyloxin
CORAL SPRINGS, Fla. — Nutra Pharma on Tuesday announced that they have begun shipping the initial product orders to MyNyloxin, a new company that has the exclusive rights to market and distribute Nutra Pharma’s over-the-counter pain reliever, Nyloxin, in the network marketing channel.
Nutra Pharma previously announced the launch of the MyNyloxin website that allows for product sales and information as well as allowing distributors to sign up and view the network marketing opportunity. Nutra Pharma will continue to market the products through their retail and direct response distributors.
"Our independent entrepreneurs are excited to begin distributing Nyloxin and sharing this opportunity," said Dalton Johnson, CEO of MyNyloxin.com. "By providing access to a superior pain relief product that customers need and can trust, and by providing an innovative network marketing program that offers a fair and balanced compensation plan for both the average and ambitious MyNyloxin Independent Entrepreneur (MIE), we believe that we will change lives for the better."
Nutra Pharma recently announced the beginning of marketing efforts by New Vitality for the direct response and retail marketing of Nyloxin. New Vitality’s first Nyloxin television commercials are scheduled to begin shortly.